Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN67,9367,96-0,73
Msft7,63
Nokia4,3854,451,06
IBM-0,89
Mercedes-Benz Group AG52,6252,65-2,73
PFE-1,97
02.05.2025 1:38:47
Indexy online
AD Index online
select
AD Index online
 

  • 01.05.2025
ConvaTec Grp Rg (London)
Závěr k 1.5.2025 Změna (%) Změna (GBP) Objem obchodů (GBP)
2,62 0,69 0,02 5 197 473
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 02.05.2025
Popis společnosti
Obecné informace
Název společnostiConvaTec Group PLC
TickerCTEC
Kmenové akcie:Ordinary Shares
RICCTEC.L
ISINGB00BD3VFW73
Prioritní akcieRedeem. Pref. Shrs
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky31.12.2024
Počet zaměstnanců k 31.12.2024 10 483
Akcie v oběhu k 31.12.20242 049 789 559
MěnaUSD
Kontaktní informace
Ulice7th Floor, 20 Eastbourne Terrace
MěstoLONDON
PSČW2 6LG
ZeměUnited Kingdom
Kontatní osoba 
Funkce kontaktní osoby 

Business Summary: Convatec Group Plc is a United Kingdom-based medical products and technologies company. The Company is engaged in the development, manufacture and sale of medical products, services, and technologies. It is focused on solutions for the management of chronic conditions. It markets and sells its solutions and services in four categories, such as Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Advanced Wound Care includes advanced dressings for the management of acute and chronic wounds resulting from ongoing conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. Ostomy Care includes devices, accessories, and personalized services for individuals with a stoma. Continence and Critical Care includes products and services for people with urinary continence issues related to spinal cord injuries and other causes. Infusion Care includes disposable infusion sets used in insulin pump therapy for people with diabetes.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2024, ConvaTec Group PLC revenues increased 7% to $2.29B. Net income increased 46% to $190.5M. Revenues reflect Advanced Wound Care segment increase of 7% to $742.7M, Continence & Critical Care segment increase of 10% to $501.4M, U.S segment increase of 9% to $896M, Other segment increase of 4% to $864.3M.
Odvětvová klasifikace
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical Appliance and Supplies Manufacturing
NAICS2007Surgical Appliance & Supplies Mfg
NAICS1997Surgical Appliance and Supplies Manufacturing
SICSurgical Appliances And Supplies



  • Poslední aktualizace: 02.05.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Executive DirectorKarim Bitar-30.09.201930.09.2019
Chief Financial Officer, Executive DirectorJonny Mason-12.03.202231.01.2022
President and Chief Operating Officer - Global Emerging MarketsAnne Belcher-01.01.2022
President and Chief Operating Officer - Infusion CareKjersti Grimsrud-01.01.2018
President and Chief Operating Officer - Continence Care and Home Services GroupMark Jassey-
President and Chief Operating Officer - Ostomy CareBruno Pinheiro-
President and Chief Operating Officer - Advanced Wound CareDavid Shepherda-19.11.2018
Executive Vice President, Chief Quality and Operations OfficerJohn Haller-01.01.2022
Chief Human Resource Officer, Executive Vice PresidentEmma Rosei-
Executive Vice President, Chief Technology Officer and Head - Research and DevelopmentDivakar Ramakrishnan-21.01.2020